FCM
Farallon Capital Management’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-381,330
| Closed | -$166M | – | 161 |
|
2023
Q3 | $166M | Sell |
381,330
-64,000
| -14% | -$27.9M | 0.78% | 36 |
|
2023
Q2 | $198M | Sell |
445,330
-228,300
| -34% | -$101M | 0.99% | 32 |
|
2023
Q1 | $310M | Buy |
673,630
+39,330
| +6% | +$18.1M | 1.69% | 19 |
|
2022
Q4 | $325M | Sell |
634,300
-167,100
| -21% | -$85.7M | 1.92% | 17 |
|
2022
Q3 | $364M | Sell |
801,400
-25,082
| -3% | -$11.4M | 2% | 8 |
|
2022
Q2 | $399M | Buy |
826,482
+57,707
| +8% | +$27.8M | 2.16% | 7 |
|
2022
Q1 | $378M | Buy |
768,775
+13,715
| +2% | +$6.74M | 1.82% | 13 |
|
2021
Q4 | $350M | Sell |
755,060
-99,905
| -12% | -$46.3M | 1.75% | 17 |
|
2021
Q3 | $319M | Buy |
854,965
+204,965
| +32% | +$76.4M | 1.49% | 22 |
|
2021
Q2 | $248M | Sell |
650,000
-175,000
| -21% | -$66.8M | 1.01% | 33 |
|
2021
Q1 | $296M | Sell |
825,000
-450,000
| -35% | -$162M | 1.47% | 23 |
|
2020
Q4 | $409M | Hold |
1,275,000
| – | – | 2.46% | 11 |
|
2020
Q3 | $342M | Buy |
1,275,000
+25,000
| +2% | +$6.71M | 2.37% | 13 |
|
2020
Q2 | $329M | Hold |
1,250,000
| – | – | 2.63% | 11 |
|
2020
Q1 | $284M | Hold |
1,250,000
| – | – | 2.44% | 14 |
|
2019
Q4 | $378M | Buy |
1,250,000
+187,117
| +18% | +$56.5M | 2.55% | 6 |
|
2019
Q3 | $255M | Buy |
1,062,883
+12,883
| +1% | +$3.09M | 1.93% | 12 |
|
2019
Q2 | $296M | Buy |
1,050,000
+225,000
| +27% | +$63.5M | 1.93% | 10 |
|
2019
Q1 | $237M | Sell |
825,000
-225,000
| -21% | -$64.6M | 1.78% | 14 |
|
2018
Q4 | $276M | Buy |
1,050,000
+15,000
| +1% | +$3.94M | 2.02% | 15 |
|
2018
Q3 | $284M | Hold |
1,035,000
| – | – | 1.68% | 15 |
|
2018
Q2 | $246M | Buy |
1,035,000
+45,000
| +5% | +$10.7M | 1.52% | 20 |
|
2018
Q1 | $218M | Buy |
990,000
+167,000
| +20% | +$36.7M | 1.51% | 18 |
|
2017
Q4 | $185M | Buy |
823,000
+613,000
| +292% | +$138M | 1.5% | 18 |
|
2017
Q3 | $39.9M | Hold |
210,000
| – | – | 0.35% | 45 |
|
2017
Q2 | $39.5M | Buy |
+210,000
| New | +$39.5M | 0.41% | 41 |
|